• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜小动脉的壁腔比与尿白蛋白排泄有关,并改变了对一氧化氮合酶抑制剂 N-单甲基-L-精氨酸输注的血管反应性。

Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine.

机构信息

Department of Nephrology and Hypertension, University of Erlangen-Nürnberg, Germany.

出版信息

J Hypertens. 2009 Nov;27(11):2201-8. doi: 10.1097/HJH.0b013e32833013fd.

DOI:10.1097/HJH.0b013e32833013fd
PMID:19625969
Abstract

OBJECTIVE

We hypothesized that wall-to-lumen ratio (WLR) of retinal arterioles might serve as an in-vivo parameter of vascular damage. To test this hypothesis we examined whether WLR of retinal arterioles is related with increased urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine (L-NMMA).

METHODS

Thirty-nine never-treated male patients aged 18-65 years with a body mass index at least 25 kg/m(2) and without diabetes mellitus or secondary or stage 3 arterial hypertension were examined. WLR of retinal arterioles was assessed using scanning laser Doppler flowmetry. Urinary albumin-to-creatinine ratio (UACR) was measured from first morning spot urine. Vascular reactivity was measured by the change of aortic augmentation index (aAIx) to infusion of L-NMMA.

RESULTS

UACR was related with WLR of retinal arterioles (r = 0.352, P = 0.032). In response to L-NMMA infusion aAIx increased (from 10.7 +/- 11 to 19.7 +/- 11%, P < 0.001). The change of aAIx to L-NMMA infusion was inversely related with WLR of retinal arterioles (r = -0.462, P = 0.003) even after adjustment for changes of hemodynamic parameters to L-NMMA infusion (partial r = -0.475, P = 0.005). The relationships of UACR and the change of aAIx to L-NMMA infusion with WLR of retinal arterioles were found to be independently of other cardiovascular risk factors (ss = 0.386, P = 0.006; ss = -0.369, P = 0.004, respectively) in multiple regression analyses with separate models for both parameters.

CONCLUSION

Increased WLR of retinal arterioles may thus serve as an in-vivo marker of vascular damage.

摘要

目的

我们假设视网膜小动脉的壁腔比(WLR)可能作为血管损伤的体内参数。为了验证这一假设,我们研究了视网膜小动脉的 WLR 是否与尿白蛋白排泄增加和血管对一氧化氮合酶抑制剂 N-单甲基-L-精氨酸(L-NMMA)输注的反应性改变有关。

方法

检查了 39 名未经治疗的年龄在 18-65 岁之间的男性患者,这些患者的体重指数至少为 25kg/m(2),且无糖尿病或继发性或 3 期动脉高血压。使用扫描激光多普勒血流仪评估视网膜小动脉的 WLR。从第一次晨尿中测量尿白蛋白/肌酐比值(UACR)。通过 L-NMMA 输注测量主动脉增强指数(aAIx)的变化来测量血管反应性。

结果

UACR 与视网膜小动脉的 WLR 相关(r=0.352,P=0.032)。在 L-NMMA 输注后,aAIx 增加(从 10.7 +/- 11 增加到 19.7 +/- 11%,P < 0.001)。L-NMMA 输注后 aAIx 的变化与视网膜小动脉的 WLR 呈负相关(r=-0.462,P=0.003),即使在校正了对 L-NMMA 输注的血流动力学参数的变化后(部分 r=-0.475,P=0.005)。在多元回归分析中,使用两个参数的单独模型,UACR 和 aAIx 对 L-NMMA 输注的变化与视网膜小动脉的 WLR 之间的关系被发现是独立于其他心血管危险因素的(ss=0.386,P=0.006;ss=-0.369,P=0.004)。

结论

因此,视网膜小动脉的 WLR 增加可能作为血管损伤的体内标志物。

相似文献

1
Wall-to-lumen ratio of retinal arterioles is related with urinary albumin excretion and altered vascular reactivity to infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine.视网膜小动脉的壁腔比与尿白蛋白排泄有关,并改变了对一氧化氮合酶抑制剂 N-单甲基-L-精氨酸输注的血管反应性。
J Hypertens. 2009 Nov;27(11):2201-8. doi: 10.1097/HJH.0b013e32833013fd.
2
Influence of blood flow on arteriolar wall-to-lumen ratio in the human retinal circulation in vivo.血流对活体人视网膜循环中小动脉壁腔比的影响。
Microvasc Res. 2012 Mar;83(2):111-7. doi: 10.1016/j.mvr.2011.10.002. Epub 2011 Oct 19.
3
Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.一氧化氮在静脉注射血管内皮生长因子诱导的高通透性和血流动力学变化中的作用。
Invest Ophthalmol Vis Sci. 1999 Mar;40(3):689-96.
4
Wall-to-lumen ratio of retinal arterioles and arteriole-to-venule ratio of retinal vessels in patients with cerebrovascular damage.脑血管损伤患者视网膜小动脉的壁腔比及视网膜血管的动静脉比
Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4351-9. doi: 10.1167/iovs.08-3266. Epub 2009 Apr 1.
5
Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.一氧化氮合酶抑制剂对清醒大鼠血管紧张素II升压反应的影响。
Artery. 1998;23(1):1-9.
6
Nitric oxide synthase inhibitors affect nitric oxide synthesis in normoxic but not in ischemic organs during intestinal ischemia and early reperfusion.一氧化氮合酶抑制剂在肠缺血和早期再灌注期间影响正常氧合器官而非缺血器官中的一氧化氮合成。
J Lab Clin Med. 2002 Nov;140(5):303-11. doi: 10.1067/mlc.2002.128180.
7
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.代偿期肝硬化时急性抑制一氧化氮合酶的血流动力学、肾脏及内分泌效应
Hepatology. 2001 Jul;34(1):19-27. doi: 10.1053/jhep.2001.25756.
8
Calcium-independent release of endothelial nitric oxide in the arteriolar network: onset during rapid juvenile growth.小动脉网络中内皮一氧化氮的钙非依赖性释放:在青少年快速生长期间开始。
Microcirculation. 2004 Sep;11(6):453-62. doi: 10.1080/10739680490475999.
9
L-arginine-induced growth hormone secretion is not influenced by co-infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine in healthy men.在健康男性中,L-精氨酸诱导的生长激素分泌不受一氧化氮合酶抑制剂N-单甲基-L-精氨酸共同输注的影响。
Growth Horm IGF Res. 1999 Feb;9(1):69-73. doi: 10.1054/ghir.1999.0089.
10
Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats.一氧化氮合酶(NOS)抑制剂可改善大鼠缺血诱导的视网膜损伤。
Res Commun Mol Pathol Pharmacol. 1996 Jun;92(3):329-40.

引用本文的文献

1
Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease?高血压中的微循环:预防心血管疾病的治疗靶点?
J Clin Med. 2023 Jul 25;12(15):4892. doi: 10.3390/jcm12154892.
2
Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies.动脉高血压与眼睛的隐匿性疾病:诊断工具与治疗策略。
Nutrients. 2022 May 25;14(11):2200. doi: 10.3390/nu14112200.
3
Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.未经治疗的轻中度高血压患者的视网膜毛细血管稀疏
BMC Cardiovasc Disord. 2017 Dec 21;17(1):300. doi: 10.1186/s12872-017-0732-x.
4
Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients.缬沙坦治疗高血压患者后视网膜毛细血管稀疏的改善情况。
J Clin Hypertens (Greenwich). 2016 Nov;18(11):1112-1118. doi: 10.1111/jch.12851. Epub 2016 Jun 16.
5
Retinal Microcirculation in Type 1 Diabetic Patients With and Without Peripheral Sensory Neuropathy.1型糖尿病伴或不伴周围感觉神经病变患者的视网膜微循环
J Diabetes Sci Technol. 2014 Mar;8(2):356-361. doi: 10.1177/1932296814524092. Epub 2014 Feb 21.
6
Retinal arterial hypertrophy: the new LVH?视网膜动脉肥厚:新的 LVH?
Curr Hypertens Rep. 2013 Jun;15(3):244-52. doi: 10.1007/s11906-013-0347-2.
7
Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study.维格列汀联合二甲双胍可改善2型糖尿病患者的视网膜血流和红细胞变形性——一项探索性研究的结果
Cardiovasc Diabetol. 2013 Apr 8;12:59. doi: 10.1186/1475-2840-12-59.
8
Treatment of arterial remodeling in essential hypertension.原发性高血压的动脉重构治疗。
Curr Hypertens Rep. 2013 Feb;15(1):3-9. doi: 10.1007/s11906-012-0325-0.
9
Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabetes mellitus.评估胰岛素抵抗和/或2型糖尿病患者视网膜血流形态和功能变化的初步研究。
J Diabetes Sci Technol. 2012 Jan 1;6(1):163-8. doi: 10.1177/193229681200600120.
10
How to assess microvascular structure in humans.如何评估人体的微血管结构。
High Blood Press Cardiovasc Prev. 2011 Dec 1;18(4):169-77. doi: 10.2165/11593640-000000000-00000.